 |
 |
Drugs and Treatment
A New Class of Cancer Drugs May Be Less Toxic
New York Times (06/01/12) Pollack, Andrew
Pharmaceutical companies are working on the development of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. The drugs chemically attach a toxin to read more...
Return to Headlines
Afatinib Delivers Unprecedented First Line Efficacy in Patients With EGFR Mutation Positive Lung Cancer in Registration Trial
Boehringer Ingelheim Pharmaceuticals Press Release (06/04/12)
Boehringer Ingelheim has released the results of its LUX-Lung 3 Phase III study, which compared the use of the novel compound afatinib and standard chemotherapy in the treatment of lung cancer. The study found read more...
Return to Headlines
Amylin Pharmaceuticals to Present Data on BYDUREON, BYETTA and SYMLIN at the American Diabetes Association 2012 Meeting
Amylin Pharmaceuticals Press Release (06/04/12)
Amylin Pharmaceuticals will present data for BYDUREON (exenatide extended-release for injectable suspension), the first and only once-weekly diabetes treatment, as well as first-in-class diabetes drugs read more...
Return to Headlines
Amyvid Now Available in Select U.S. Markets
Eli Lilly and Company Press Release (06/01/12)
Eli Lilly and Avid Radiopharmaceuticals, a wholly owned subsidiary of Lilly, have announced that Amyvid (Florbetapir F 18 Injection) is available to imaging centers in markets surrounding 16 manufacturing sites in read more...
Return to Headlines
Genentech Data Showed That People With Metastatic Colorectal Cancer Lived Longer When They Continued on Avastin Plus Chemotherapy
Genentech Press Release (06/02/12)
Genentech has announced the results of a study that looked at the use of Avastin and chemotherapy in treating people with metastatic colorectal cancer (mCRC) who had already been given Avastin and first-line read more...
Return to Headlines
Genentech Study Showed That Adding Avastin to Chemotherapy Cut the Risk of the Disease Getting Worse in Difficult-to-Treat Recurrent Ovary Cancer
Genentech Press Release (06/01/12)
The use of Avastin in combination with chemotherapy can result in a significant improvement in progression-free survival (PFS) in the treatment of platinum-resistant ovarian cancer, a new study by Genentech has read more...
Return to Headlines
Genentech's Targeted Investigational Breast Cancer Medicine, Trastuzumab Emtansine, Reduced the Risk of Cancer Worsening or Death by 35 Percent
Genentech Press Release (06/02/12)
Genentech has released the results of its Phase III EMILIA study of trastuzumab emtansine (T-DM1), which involved nearly 1,000 people with HER2-positive locally advanced or metastatic breast cancer whose disease continued to read more...
Return to Headlines
Janssen Research & Development Submits New Drug Application to FDA for Canagliflozin to Treat Patients With Type 2 Diabetes
Johnson & Johnson Press Release (05/31/12)
Janssen Research & Development is asking the U.S. Food and Drug Administration to approve the use of the selective sodium glucose co-transporter 2 (SGLT2) inhibitor canagliflozin for the treatment of adults with read more...
Return to Headlines
Purdue Pharma Presents Data on Physician Understanding of the REMS for Butrans Transdermal System CIII Data
Purdue Pharma Press Release (06/04/12)
Purdue Pharma has presented data evaluating physician understanding of the Risk Evaluation and Mitigation Strategy (REMS) for Butrans (buprenorphine) Transdermal System CIII at the International Society for read more...
Return to Headlines
Zinc Helps Fight Infant Infections
MedPage Today (05/30/12) Phend, Crystal
The results of a randomized clinical trial reported online in The Lancet show that adding oral zinc to standard antibiotics when treating serious infection in infants reduced the risk of treatment failure by 40 percent compared to read more...
Return to Headlines
Zytiga Plus Prednisone Show Improvements in Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prosta
Johnson & Johnson Press Release (06/02/12)
Janssen Research & Development has released the results of its study on the effectiveness of using both Zytiga and prednisone in treating patients with metastatic castration-resistant prostate cancer. The study of read more...
Return to Headlines
|
|
|
Industry News
Berne Ingelheim Launches First-of-a-Kind Fundraising Model to Support Disease Awareness Projects
Boehringer Ingelheim Pharmaceuticals Press Release (06/01/12)
Boehringer Ingelheim has partnered with the fundraising firm ammado to launch an online platform will be used to support a project that aims to prevent atrial fibrillation-related strokes. The platform, which will be read more...
Return to Headlines
New Mobile App Helps Doctors Find Clinical Trials for Cancer Patients
Eli Lilly and Company Press Release (06/01/12)
Eli Lilly has launched a searchable clinical trial mobile application for oncology healthcare professionals. The app allows healthcare professionals to search oncology trials that are enrolling read more...
Return to Headlines
|
|
|
Healthcare Legislation & Regulation and Medicaid/Medicare
FDA to Let Women Try New Breast Drugs Earlier
MSNBC (06/03/12) Steenhuysen, Julie
The FDA has issued a new guidance document that will allow drug companies to test their medications for short period of time on women with a highly aggressive breast cancer called triple-negative breast cancer. If the read more...
Return to Headlines
|
|
|
Recalls and Alerts
Drug Shortages Update - June 1, 2012
read more...
Return to Headlines
Drug Shortages Update - June 4, 2012
read more...
Return to Headlines
Drug Shortages Update - June 5, 2012
read more...
Return to Headlines
|
Abstract News © Copyright 2012 INFORMATION, INC.
 |
|
|
FEATURED SPONSOR:
|
|
